BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 18355783)

  • 1. Enhancing patient autonomy with risk assessment and invasive diagnosis: an ethical solution to a clinical challenge.
    Chervenak FA; McCullough LB; Sharma G; Davis J; Gross S
    Am J Obstet Gynecol; 2008 Jul; 199(1):19.e1-4. PubMed ID: 18355783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical considerations of early (first vs. second trimester) risk assessment disclosure for trisomy 21 and patient choice in screening versus diagnostic testing.
    Sharma G; McCullough LB; Chervenak FA
    Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):99-104. PubMed ID: 17299736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical considerations in first-trimester Down syndrome risk assessment.
    Chervenak FA; McCullough LB
    Curr Opin Obstet Gynecol; 2010 Apr; 22(2):135-8. PubMed ID: 20125014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconsidering prenatal screening: an empirical-ethical approach to understand moral dilemmas as a question of personal preferences.
    García E; Timmermans DR; van Leeuwen E
    J Med Ethics; 2009 Jul; 35(7):410-4. PubMed ID: 19567688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lethal autonomy: the malfunction of the informed consent mechanism within the context of prenatal diagnosis of genetic variants.
    Dunne C; Warren C
    Issues Law Med; 1998; 14(2):165-202. PubMed ID: 9807244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informed consent: providing information about prenatal examinations.
    Dahl K; Kesmodel U; Hvidman L; Olesen F
    Acta Obstet Gynecol Scand; 2006; 85(12):1420-5. PubMed ID: 17260215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of the ethics of informed consent for first-trimester risk assessment for trisomy 21.
    Chervenak FA; McCullough LB; Chasen ST
    Semin Perinatol; 2005 Aug; 29(4):277-9. PubMed ID: 16104682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ethically justified, clinically comprehensive management strategy for third-trimester pregnancies complicated by fetal anomalies.
    Chervenak FA; McCullough LB
    Obstet Gynecol; 1990 Mar; 75(3 Pt 1):311-6. PubMed ID: 2304702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When pregnant patients refuse interventions.
    Tauer CA
    AWHONNS Clin Issues Perinat Womens Health Nurs; 1993; 4(4):596-605. PubMed ID: 8220374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of first-trimester risk assessment for trisomy 21: ethical considerations.
    Chervenak FA; McCullough LB
    Am J Obstet Gynecol; 2005 Jun; 192(6):1777-81. PubMed ID: 15970806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical dimensions of first-trimester fetal aneuploidy screening.
    Chervenak FA; McCullough LB
    Clin Obstet Gynecol; 2014 Mar; 57(1):226-31. PubMed ID: 24351442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal screening: current practice, new developments, ethical challenges.
    de Jong A; Maya I; van Lith JM
    Bioethics; 2015 Jan; 29(1):1-8. PubMed ID: 25521968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Noninvasive prenatal genetic diagnosis: a bioethical reflection on the use of noninvasive prenatal diagnosis from the analysis of nucleic acids present in maternal peripheral blood].
    González-Melado FJ; Di Pietro ML
    Cuad Bioet; 2011; 22(74):49-75. PubMed ID: 21692554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ethically justified decision-making pathway for the management of pregnancies complicated by twin-to-twin transfusion syndrome.
    Skupski D; Chervenak FA; McCullough L
    Fetal Diagn Ther; 2007; 22(5):339-42. PubMed ID: 17556820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new genetics and informed consent: differentiating choice to preserve autonomy.
    Bunnik EM; de Jong A; Nijsingh N; de Wert GM
    Bioethics; 2013 Jul; 27(6):348-55. PubMed ID: 23718722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Information preferences of high literacy pregnant women regarding informed consent models for genetic carrier screening.
    Ormond KE; Banuvar S; Daly A; Iris M; Minogue J; Elias S
    Patient Educ Couns; 2009 May; 75(2):244-50. PubMed ID: 19013744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The federal government and academic texts as barriers to informed consent.
    Lanfranchi A
    Issues Law Med; 2008; 24(1):61-9. PubMed ID: 18771039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical considerations in prenatal diagnosis.
    Gates EA
    West J Med; 1993 Sep; 159(3):391-5. PubMed ID: 8236982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Patient autonomy and informed consent in clinical practice].
    Pedersen R; Hofmann B; Mangset M
    Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1644-7. PubMed ID: 17571103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethics, an emerging subdiscipline of obstetric ultrasound, and its relevance to the routine obstetric scan.
    Chervenak FA; McCullough LB
    Ultrasound Obstet Gynecol; 1991 Jan; 1(1):18-20. PubMed ID: 12797097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.